Ted Monohon - 05 Dec 2022 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Chief Accounting Officer & VP
Signature
/s/ Ted Monohon
Issuer symbol
QNCX
Transactions as of
05 Dec 2022
Net transactions value
-$1,181
Form type
4
Filing time
07 Dec 2022, 16:37:47 UTC
Previous filing
08 Sep 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Tax liability $1,181 -1,640 -5.3% $0.7200 29,311 05 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022.